Antonio Rodriguez-Calero
Overview
Explore the profile of Antonio Rodriguez-Calero including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
70
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dutta A, Rodriguez-Calero A, Ronaldson-Bouchard K, Offermann A, Rahman D, Vhatkar T, et al.
Mol Cancer Res
. 2025 Feb;
PMID: 39907729
Metastasis accounts for the overwhelming majority of cancer deaths. In prostate cancer and many other solid tumors, progression to metastasis is associated with drastically reduced survival outcomes, yet the mechanisms...
2.
Giudici N, Schoch A, Genitsch V, Rodriguez-Calero A, Thalmann G, Seiler R
Urol Oncol
. 2024 Nov;
PMID: 39580343
No abstract available.
3.
Nunes de Almeida F, Vasciaveo A, Antao A, Zou M, Di Bernardo M, de Brot S, et al.
bioRxiv
. 2024 Sep;
PMID: 39253480
Summary: Using an unbiased forward mutagenesis screen in an autochthonous mouse model, we have investigated mechanistic determinants of aggressive prostate cancer. SIRT1 emerged as a key regulator of neuroendocrine prostate...
4.
Landry C, Rodriguez-Calero A, Vogt B, Bocchi F
Front Med (Lausanne)
. 2024 Jun;
11:1379547.
PMID: 38831990
Idiopathic nodular glomerulosclerosis (ING) is a rare condition characterized by poor renal prognosis. The pathophysiology remains incompletely understood. Histologically, it closely resembles diabetic nephropathy. The development of this disease seems...
5.
Minoli M, Cantore T, Hanhart D, Kiener M, Fedrizzi T, La Manna F, et al.
Nat Commun
. 2023 Apr;
14(1):2214.
PMID: 37072390
Bladder Cancer (BLCa) inter-patient heterogeneity is the primary cause of treatment failure, suggesting that patients could benefit from a more personalized treatment approach. Patient-derived organoids (PDOs) have been successfully used...
6.
Rosenstock P, Komarek C, Rodriguez-Calero A, Oestmann A
Praxis (Bern 1994)
. 2023 Mar;
112(4):231-234.
PMID: 36919315
A Rare Cause for B Symptoms The 78-year-old patient was referred by her general practitioner for a tumor search after a 3-month deterioration of her general condition, B-symptomatology, persistently elevated...
7.
Gallon J, Rodriguez-Calero A, Benjak A, Akhoundova D, Maletti S, Amstutz U, et al.
Cancer Res
. 2023 Feb;
83(8):1203-1213.
PMID: 36749655
Significance: DNA methylation analysis reveals the molecular characteristics of PCBM and may serve as a starting point for efforts to identify and target susceptibilities of these rare metastases.
8.
Vasciaveo A, Arriaga J, Nunes de Almeida F, Zou M, Douglass E, Picech F, et al.
Cancer Discov
. 2022 Nov;
13(2):386-409.
PMID: 36374194
Significance: OncoLoop is a transcriptomic-based experimental and computational framework that can support rapid-turnaround coclinical studies to identify and validate drugs for individual patients, which can then be readily adapted to...
9.
Rodriguez-Calero A, Gallon J, Akhoundova D, Maletti S, Ferguson A, Cyrta J, et al.
Nat Commun
. 2022 May;
13(1):2400.
PMID: 35504881
Improved survival rates for prostate cancer through more effective therapies have also led to an increase in the diagnosis of metastases to infrequent locations such as the brain. Here we...
10.
Papachristodoulou A, Rodriguez-Calero A, Panja S, Margolskee E, Virk R, Milner T, et al.
Cancer Discov
. 2021 Apr;
11(9):2316-2333.
PMID: 33893149
Mitochondria provide the first line of defense against the tumor-promoting effects of oxidative stress. Here we show that the prostate-specific homeoprotein NKX3.1 suppresses prostate cancer initiation by protecting mitochondria from...